More on ARCT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+87.8% Growth)
- Ratings (6.2 Score)
- Holders
- Dividends (4.4% Yield)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Arcturus Therapeutics (NQ:ARCT)
Delayed: 16.23 +1.47 (9.96%)
Prev. Close $14.76  
Open$14.87 
52 Wk High$13.09 
52 Wk Low$5.54 
Day High$16.85 
Day Low$14.86 
P/E N/A  
EPS$-0.38 
Volume1,368,217 

Friends, Peers and Foes (?): ALNY, DNLI, OTLC SRPT (more...)

Aug 25, 2026 06:05 AM Form 8-K Arcturus Therapeutics For: Aug 25
Aug 6, 2026 05:14 PM Arcturus Therapeutics (ARCT) Tops Q2 EPS by 21c
Aug 6, 2026 04:28 PM Form 10-Q Arcturus Therapeutics For: Jun 30
Aug 6, 2026 04:07 PM Form 8-K Arcturus Therapeutics For: Aug 06
Aug 6, 2026 04:01 PM Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress
Jul 28, 2026 04:01 PM Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026
Jul 20, 2026 04:01 PM Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
Jul 2, 2026 07:06 AM Form 8-K Arcturus Therapeutics For: Jun 26
Jul 2, 2026 07:00 AM Arcturus and Thermo Fisher partner on cystic fibrosis mRNA therapy
Jul 2, 2026 07:00 AM Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis
View All Articles

Entities mentioned with ARCT

View All Entities